The onset of pneumonitis symptoms in patients treated with anti‐PD‐1/PD‐L1 therapies has been found to be variable, ranging from days to over a year after treatment initiation with the median time to onset found to be 2.8 months in a prior study.22 Here, CD274 is linked to pneumonitis.